Announcements Trials
Browse Landscape

Phase

Phase 2 143Phase 1/2 52Phase 3 49Phase 1 40Phase 2/3 10Phase NA 9Phase 4 5Phase EARLY_PHASE1 2

Status

Completed 14Recruiting 5Terminated 4Withdrawn 2Unknown 2Not yet recruiting 2Active not recruiting 1

Sponsor Class

OTHER 5

Study Type

Interventional 5

Sponsor

Cancer Type

Gastrointestinal 3Tumor-Agnostic 1Other solid neoplasm 1

Conditions

Carcinoma, Hepatocellular 2Solid Tumor 1Neoplasms 1Locally Advanced Colorectal Cancer 1Liver Neoplasms 1

Interventions

Propofol 9Sevoflurane 7Rituximab 7Specimen Handling 6Magnetic Resonance Spectroscopy 6Dexamethasone 6Trastuzumab 5Enoxaparin 5Bevacizumab 5Nivolumab 4Carboplatin 4Capecitabine 4Bupivacaine 4trametinib 3pirtobrutinib 3pembrolizumab 3dabrafenib 3atezolizumab 3apixaban 3Lenalidomide 3Indocyanine Green 3Gemcitabine 3Docetaxel 3Cyclophosphamide 3zanubrutinib 2venetoclax 2trastuzumab deruxtecan 2ribociclib 2polyethylene glycol 3350 2pertuzumab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 4 × Recruiting × Bevacizumab × Clear all
NCT06031233 2026-03-30

MINUTE

Isala

Phase 4 Recruiting
776 enrolled
Tumor-Agnostic

Neoplasms

NCT07059494 2026-03-23

Atezolizumab and Bevacizumab in Combination With Y^90 Radioembolization in HCC for Liver Transplant

Icahn School of Medicine at Mount Sinai

Phase 4 Recruiting
40 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT05525767 2025-12-11

Chemotherapy Combined With Bevacizumab Neoadjuvant Therapy for HER2-negative Breast Cancer

Hebei Medical University Fourth Hospital

Phase 4 Recruiting
75 enrolled
Other solid neoplasm

Solid Tumor

NCT06550453 2024-11-12

Safety and Efficacy of Pembrolizumab in Combination with Bevacizumab + CapeOX in the Neoadjuvant Treatment of RAS-mutated, BRAF Wild-type, Microsatellite-stabilized, Locally Advanced Colorectal Cancer

Xijing Hospital

Phase 4 Recruiting
20 enrolled
Gastrointestinal

Locally Advanced Colorectal Cancer

NCT05185505 2023-02-01

Atezolizumab and Bevacizumab Pre-Liver Transplantation for Patients With Hepatocellular Carcinoma Beyond Milan Criteria

The Methodist Hospital Research Institute

Phase 4 Recruiting
24 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡